BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 31187488)

  • 1. Circle RNA hsa_circRNA_100290 serves as a ceRNA for miR-378a to regulate oral squamous cell carcinoma cells growth via Glucose transporter-1 (GLUT1) and glycolysis.
    Chen X; Yu J; Tian H; Shan Z; Liu W; Pan Z; Ren J
    J Cell Physiol; 2019 Nov; 234(11):19130-19140. PubMed ID: 31187488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA-p23154 promotes the invasion-metastasis potential of oral squamous cell carcinoma by regulating Glut1-mediated glycolysis.
    Wang Y; Zhang X; Wang Z; Hu Q; Wu J; Li Y; Ren X; Wu T; Tao X; Chen X; Li X; Xia J; Cheng B
    Cancer Lett; 2018 Oct; 434():172-183. PubMed ID: 30026052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. hsa_circRNA_100533 regulates GNAS by sponging hsa_miR_933 to prevent oral squamous cell carcinoma.
    Zhu X; Shao P; Tang Y; Shu M; Hu WW; Zhang Y
    J Cell Biochem; 2019 Nov; 120(11):19159-19171. PubMed ID: 31297884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. hsa_circ_0072387 Suppresses Proliferation, Metastasis, and Glycolysis of Oral Squamous Cell Carcinoma Cells by Downregulating miR-503-5p.
    Han L; Cheng J; Li A
    Cancer Biother Radiopharm; 2021 Feb; 36(1):84-94. PubMed ID: 32302508
    [No Abstract]   [Full Text] [Related]  

  • 5. Circ-PVT1/miR-106a-5p/HK2 axis regulates cell growth, metastasis and glycolytic metabolism of oral squamous cell carcinoma.
    Zhu X; Du J; Gu Z
    Mol Cell Biochem; 2020 Nov; 474(1-2):147-158. PubMed ID: 32737775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SLC2A1-AS1 induced by GLI3 promotes aerobic glycolysis and progression in esophageal squamous cell carcinoma by sponging miR-378a-3p to enhance Glut1 expression.
    Liu H; Zhang Q; Song Y; Hao Y; Cui Y; Zhang X; Zhang X; Qin Y; Zhu G; Wang F; Dang J; Ma S; Zhang Y; Guo W; Li S; Guan F; Fan T
    J Exp Clin Cancer Res; 2021 Sep; 40(1):287. PubMed ID: 34517880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. m
    Cui Y; Liu J; Liu L; Ma X; Gui Y; Liu H; Zhao W
    Cancer Gene Ther; 2023 Jan; 30(1):163-171. PubMed ID: 36127411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. circ-PKD2 inhibits carcinogenesis via the miR-204-3p/APC2 axis in oral squamous cell carcinoma.
    Gao L; Zhao C; Li S; Dou Z; Wang Q; Liu J; Ren W; Zhi K
    Mol Carcinog; 2019 Oct; 58(10):1783-1794. PubMed ID: 31206208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microarray profile of circular RNAs identifies hsa_circRNA_102459 and hsa_circRNA_043621 as important regulators in oral squamous cell carcinoma.
    Deng W; Peng W; Wang T; Chen J; Qiu X; Fu L; Zhu S
    Oncol Rep; 2019 Dec; 42(6):2738-2749. PubMed ID: 31638251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circMDM2 accelerates the glycolysis of oral squamous cell carcinoma by targeting miR-532-3p/HK2.
    Zheng Z; Ma X; Li H
    J Cell Mol Med; 2020 Jul; 24(13):7531-7537. PubMed ID: 32410389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. circ_0004872 inhibits proliferation, invasion, and glycolysis of oral squamous cell carcinoma by sponged miR-424-5p.
    Dai Y; Zhu Y; Xu H
    J Clin Lab Anal; 2022 Jul; 36(7):e24486. PubMed ID: 35576499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA hsa_circ_0055538 regulates the malignant biological behavior of oral squamous cell carcinoma through the p53/Bcl-2/caspase signaling pathway.
    Su W; Sun S; Wang F; Shen Y; Yang H
    J Transl Med; 2019 Mar; 17(1):76. PubMed ID: 30857544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA CCAT1 is a prognostic biomarker for the progression of oral squamous cell carcinoma via miR-181a-mediated Wnt/β-catenin signaling pathway.
    Li GH; Ma ZH; Wang X
    Cell Cycle; 2019 Nov; 18(21):2902-2913. PubMed ID: 31599709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circular RNA circDENND4C facilitates proliferation, migration and glycolysis of colorectal cancer cells through miR-760/GLUT1 axis.
    Zhang ZJ; Zhang YH; Qin XJ; Wang YX; Fu J
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2387-2400. PubMed ID: 32196590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ-KIAA0907 inhibits the progression of oral squamous cell carcinoma by regulating the miR-96-5p/UNC13C axis.
    Dong W; Zhao L; Zhang S; Zhang S; Si H
    World J Surg Oncol; 2021 Mar; 19(1):75. PubMed ID: 33715625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silencing circular RNA hsa_circ_0004491 promotes metastasis of oral squamous cell carcinoma.
    Li X; Zhang H; Wang Y; Sun S; Shen Y; Yang H
    Life Sci; 2019 Dec; 239():116883. PubMed ID: 31669576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deregulation of hsa_circ_0001971/miR-186 and hsa_circ_0001874/miR-296 signaling pathways promotes the proliferation of oral squamous carcinoma cells by synergistically activating SHP2/PLK1 signals.
    Jun W; Shaobo O; Xianhua Z; Siyu Z; Mingyang C; Xin F; Ying C; Lan L
    Sci Rep; 2021 Oct; 11(1):20561. PubMed ID: 34663837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p/IGF2BP3 Signaling.
    Liu J; Jiang X; Zou A; Mai Z; Huang Z; Sun L; Zhao J
    Cancer Res; 2021 Jan; 81(2):344-355. PubMed ID: 33203701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circular hsa_circ_0020377 regulates KLF7 by targeting miR-194-5p to facilitate tumor cell malignant behaviors and glycolysis in oral squamous cell carcinoma progression.
    Hei N; Liu P; Jin L; Peng S; Bao Y
    Funct Integr Genomics; 2023 Jan; 23(1):52. PubMed ID: 36717528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circRNA_0001971 contributes to oral squamous cell carcinoma progression via miR-186-5p/Fibronectin type III domain containing 3B axis.
    Zhang J; Peng Y; Jiang S; Li J
    J Clin Lab Anal; 2022 Mar; 36(3):e24245. PubMed ID: 35060189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.